HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meng-Meng Wang Selected Research

EM-1-NHNH2

12/2020The spinal anti-allodynic effects of endomorphin analogs with C-terminal hydrazide modification in neuropathic pain model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meng-Meng Wang Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 04/2013
5Neoplasm Metastasis (Metastasis)
01/2022 - 10/2018
4Inflammation (Inflammations)
01/2022 - 12/2015
3Migraine Disorders (Migraine)
06/2022 - 06/2018
3Pain (Aches)
06/2022 - 06/2018
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2020
3Hepatocellular Carcinoma (Hepatoma)
01/2020 - 10/2018
2Ischemia
12/2022 - 01/2022
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 02/2017
2Stomach Neoplasms (Stomach Cancer)
12/2021 - 11/2013
2Sepsis (Septicemia)
11/2021 - 12/2017
2Pneumonia (Pneumonitis)
01/2021 - 07/2011
2Pulmonary Hypertension
02/2019 - 02/2017
1Lung Neoplasms (Lung Cancer)
02/2022
1Mitochondrial Diseases (Mitochondrial Disease)
02/2022
1Abdominal Aortic Aneurysm
01/2022
1Starvation
01/2022
1Rupture
01/2022
1Melanoma (Melanoma, Malignant)
12/2021
1Glioma (Gliomas)
12/2021
1Pulmonary Edema
11/2021
1Acute Lung Injury
11/2021
1Dysbiosis
06/2021
1Obesity
06/2021
1Dyslipidemias (Dyslipidemia)
06/2021
1Diabetes Mellitus
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Ulcer
12/2020
1Hyperalgesia
12/2020
1Neuralgia (Stump Neuralgia)
12/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2011
6Pharmaceutical PreparationsIBA
02/2022 - 10/2018
4Cisplatin (Platino)FDA LinkGeneric
02/2022 - 01/2020
3Nitroglycerin (Dynamite)FDA LinkGeneric
06/2022 - 06/2018
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
3Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2020
3CalciumIBA
01/2020 - 12/2017
3Messenger RNA (mRNA)IBA
01/2020 - 12/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2022 - 01/2022
2Opioid Receptors (Opioid Receptor)IBA
06/2022 - 12/2020
2Matrix Metalloproteinases (MMPs)IBA
01/2022 - 10/2018
2ZincIBA
01/2022 - 12/2021
2LigandsIBA
01/2020 - 12/2015
2Calcitonin Gene-Related PeptideIBA
07/2018 - 06/2018
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
12/2017 - 08/2015
2L-Type Calcium Channels (Dihydropyridine Receptor)IBA
12/2017 - 08/2015
2Polysaccharides (Glycans)IBA
02/2017 - 01/2015
1Transient Receptor Potential ChannelsIBA
12/2022
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
12/2022
1ProdrugsIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1rheinIBA
01/2022
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1PlatinumIBA
01/2022
1CationsIBA
12/2021
1Evans Blue (Blue, Evans)FDA Link
11/2021
1Pravastatin (Pravachol)FDA LinkGeneric
11/2021
1Liver GlycogenIBA
06/2021
1Ethanol (Ethyl Alcohol)IBA
06/2021
1GlycogenIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Multidrug Resistance-Associated ProteinsIBA
01/2021
1EM-1-NHNH2IBA
12/2020
1EM-2-NHNH2IBA
12/2020
1naloxonazineIBA
12/2020
1norbinaltorphimineIBA
12/2020
1endomorphin 1IBA
12/2020
1endomorphin 2IBA
12/2020
1AmidesIBA
12/2020
1Opioid Analgesics (Opioids)IBA
12/2020
1HydrazinesIBA
12/2020
1Thioctic Acid (Lipoic Acid)IBA
01/2020
1Histidine DecarboxylaseIBA
01/2020
1PotassiumIBA
01/2020
1Keratin-14 (Keratin 14)IBA
01/2020
1Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA
01/2020
1Mitogen-Activated Protein Kinase 3IBA
01/2020
1Metalloproteases (Metalloproteinases)IBA
01/2020
1Phenobarbital (Luminal)FDA Link
01/2020
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
02/2019
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2019
1Phosphotransferases (Kinase)IBA
10/2018
1Sorafenib (BAY 43-9006)FDA Link
10/2018
1regorafenibIBA
10/2018
1lenvatinibIBA
10/2018
1Receptor Activity-Modifying Protein 1IBA
07/2018
1Serotonin (5 Hydroxytryptamine)IBA
07/2018

Therapy/Procedure

5Therapeutics
01/2022 - 10/2018
2Subcutaneous Injections
06/2022 - 07/2018
2Percutaneous Collagen Induction
07/2018 - 06/2018
1Drug Therapy (Chemotherapy)
01/2022
1Precision Medicine
01/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2021
1Critical Care (Surgical Intensive Care)
12/2020
1Gastrectomy
01/2020
1Esophagectomy
01/2020
1Immunotherapy
01/2020